Global Pricing and Tenders Trends: Navigating EU HTA/JCA, Digital Procurement and ESG
As global pricing and tendering environments continue to evolve, life sciences manufacturers must prepare not only for 2026—but for what comes next.
Industry Solutions
For more than 25 years, Model N has been the leader in end-to-end commercialization, revenue optimization, and compliance for pharmaceutical and medtech innovators.
Our Products
Model N delivers a platform for business reinvention, empowering companies to maximize revenue as they transform Sales, Marketing, Channels, Finance, and Legal processes.
Services & Support
Get the most out of your Model N investment with comprehensive services designed to further your business and success.
Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
Company
Model N is the commercial platform that pharmaceutical and medtech innovators rely upon to grow market access, optimize revenue, and maintain compliance.
Industry Solutions
For more than 25 years, Model N has been the leader in end-to-end commercialization, revenue optimization, and compliance for pharmaceutical and medtech innovators.
Our Products
Model N delivers a platform for business reinvention, empowering companies to maximize revenue as they transform Sales, Marketing, Channels, Finance, and Legal processes.
Services & Support
Get the most out of your Model N investment with comprehensive services designed to further your business and success.
Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
Company
Model N is the commercial platform that pharmaceutical and medtech innovators rely upon to grow market access, optimize revenue, and maintain compliance.
Industry Solutions
For more than 25 years, Model N has been the leader in end-to-end commercialization, revenue optimization, and compliance for pharmaceutical and medtech innovators.
Our Products
Model N delivers a platform for business reinvention, empowering companies to maximize revenue as they transform Sales, Marketing, Channels, Finance, and Legal processes.
Services & Support
Get the most out of your Model N investment with comprehensive services designed to further your business and success.
Ninety-six percent of pharma leaders believe that addressing issues early and throughout the gross-to-net lifecycle would materially impact their profit margins. Learn how you can optimize gross to net in 2026.
Company
Model N is the commercial platform that pharmaceutical and medtech innovators rely upon to grow market access, optimize revenue, and maintain compliance.
Advancing EU HTA/JCA milestones, accelerating digital procurement, and rising ESG expectations are fundamentally reshaping how pricing, market access, and tender decisions are made across regions, with long term implications for governance and execution.
In this joint webinar, Model N and Marbls combine strategic insight with real world execution to help organizations navigate today’s disruption while building a foundation for sustained success beyond 2026. Attendees will gain a clear understanding of what’s changing now, what’s coming next, and how leading companies are futureproofing their global pricing and tendering strategies.
You’ll Learn:
The session features a live joint demo, applied industry scenarios, and actionable takeaways designed to help cross functional teams align strategy with execution—and stay competitive in an increasingly complex global pricing and tendering landscape, well beyond 2026.
Sr. Director, Solutions Consulting
Model N
Principal and Chief Commercial Officer, Life Sciences
Marbls
Thank you for your interest in Model N. Please submit the form and our sales team will contact you within 24 hours.
We look forward to responding within one business day.